A review of common risks and pitfalls of incorporating artificial intelligence in medical devices and an overview of the regulatory framework.
Robust trends are expected to power the global digital diabetes management market.
Digital health tools and technology have the potential to dramatically improve the patient care experience, but the shift requires purposeful coordination and planned architecture.
During the COVID-19 crisis, digital forces like artificial intelligence have assisted the healthcare industry to focus on patient care while achieving improved efficiency during treatments.
When a company does not take action to become more environmentally responsible, it risks losing access to global markets.
Devices by themselves don’t improve outcomes. Better lifestyle integration is key to driving changes in patient compliance—embedding sensors into the sorts of devices people can use every day to increase opportunities for passive biometric capture and to facilitate therapeutics.
The center is working to address the delays in meeting review timelines for product submissions.
The program highlights the agency’s commitment to improving safety and supporting innovation, and is a welcome counterpart to the Breakthrough Devices Program.
A product issue could cause keys to become unresponsive or stuck, leading to infusion delays.
A global need for less invasive medical procedures and high efficacy treatments has outlined the developments of cardiovascular devices.